Table 1.
AAV | Modified mRNA | miRNA/siRNA | Small Molecules | Protein | |
---|---|---|---|---|---|
Route of Administration | Local or I.V | Local or I.V | Local or I.V | I.V or oral | Local |
Limitation of Gene Size | Yes (4.5 Kb) | No | N/A | N/A | No |
Pharmacokinetics | Long term | Short term | Short term | Long or short term | Short term |
Multiple Administration | No | Yes | Yes | Yes | Yes |
Compromised DNA
Integrity |
Yes | No | No | No | No |
Controlled Expression | No | Yes | Yes | Yes | Yes |
Gene Expression
Regulation |
Up or down | Up or down | Mostly down | Mostly down | Mostly up |
Organ Specificity | Yes | No/possibly | No | No | No |
Cell Specificity | Yes | No/possibly | No | No | No |